Voyager Therapeutics Inc

NASDAQ:VYGR  
3.20
0.00 (0.00%)
4:44:44 PM EDT: $3.21 +0.01 (+0.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)177.08M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.91 Million
Adjusted EPS-$0.53
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Voyager Therapeutics Inc Stock, NASDAQ:VYGR

75 Hayden Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.857.259.5340
Number of Employees: 162

Description

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.